Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.72)
# 1,724
Out of 5,182 analysts
310
Total ratings
58.33%
Success rate
-1.33%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Equal-Weight | $28 | $22.65 | +23.62% | 1 | Mar 30, 2026 | |
| OMDA Omada Health | Maintains: Overweight | $32 → $30 | $12.53 | +139.43% | 2 | Mar 6, 2026 | |
| VEEV Veeva Systems | Maintains: Equal-Weight | $205 → $215 | $166.57 | +29.07% | 11 | Mar 5, 2026 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $19.39 | +8.30% | 5 | Feb 25, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.14 | +86.92% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $5.71 | +5.08% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $505.12 | -15.86% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.33 | +28.62% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $38.29 | +74.98% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $210.36 | -31.55% | 15 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $175 → $210 | $199.34 | +5.35% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $186.76 | +7.09% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $1.04 | +380.77% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $56.54 | +101.63% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $37.38 | +52.49% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $70.73 | +14.52% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $21.86 | +60.11% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.64 | +22.95% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $79.57 | +132.50% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $223.03 | -25.12% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $135.32 | -68.96% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $198.81 | -20.02% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $78.79 | +58.65% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $350.63 | -79.38% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $208.90 | -6.65% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $305.98 | +59.49% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $147.55 | +100.61% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $274.72 | +33.95% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $198.39 | +158.58% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $277.56 | -0.92% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $37.28 | +136.05% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $68.38 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $75.94 | +143.61% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $204.27 | +4.27% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $105.62 | -45.09% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $346.21 | -66.21% | 15 | Jun 16, 2020 |
Waystar Holding
Mar 30, 2026
Initiates: Equal-Weight
Price Target: $28
Current: $22.65
Upside: +23.62%
Omada Health
Mar 6, 2026
Maintains: Overweight
Price Target: $32 → $30
Current: $12.53
Upside: +139.43%
Veeva Systems
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $205 → $215
Current: $166.57
Upside: +29.07%
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $19.39
Upside: +8.30%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.14
Upside: +86.92%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $5.71
Upside: +5.08%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $505.12
Upside: -15.86%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.33
Upside: +28.62%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $38.29
Upside: +74.98%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $210.36
Upside: -31.55%
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $199.34
Upside: +5.35%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $186.76
Upside: +7.09%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $1.04
Upside: +380.77%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $56.54
Upside: +101.63%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $37.38
Upside: +52.49%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $70.73
Upside: +14.52%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $21.86
Upside: +60.11%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.64
Upside: +22.95%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $79.57
Upside: +132.50%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $223.03
Upside: -25.12%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $135.32
Upside: -68.96%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $198.81
Upside: -20.02%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $78.79
Upside: +58.65%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $350.63
Upside: -79.38%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $208.90
Upside: -6.65%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $305.98
Upside: +59.49%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $147.55
Upside: +100.61%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $274.72
Upside: +33.95%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $198.39
Upside: +158.58%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $277.56
Upside: -0.92%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $37.28
Upside: +136.05%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $68.38
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $75.94
Upside: +143.61%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $204.27
Upside: +4.27%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $105.62
Upside: -45.09%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $346.21
Upside: -66.21%